https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-agitation-symptoms-associated-dementia-due-alzheimers-disease
0
0
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - FDA.gov
5/11/23 at 1:00pm
Organization
FDA.gov
Author
Office of the Commissioner
Details
41 words
Summarize
Health Conditions Business & Industrial FDA Agitation Symptoms Alzheimer's Disease - FDA.gov
The FDA granted supplemental approval to Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease
Create an account or login to join the discussion